This compound exerts an inhibitory effect on VM through the downregulation of CDH5, α-SMA, and Akt and VEGFR-2 phosphorylation in glioma cell lines and orthotopic A172 GBM mouse models [70]. The gene discussed is AKT1; the disease is glioblastoma.